Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery
ACL, Anterior Cruciate Ligament Injuries
About this trial
This is an interventional other trial for ACL focused on measuring ACL, Genicular nerve block, Anterior Cruciate Ligament Injuries, Opioid Consumption
Eligibility Criteria
Inclusion Criteria: Age 18 - 80 English speaking American Society of Anesthesiologists (ASA) I - III BMI < 35 Scheduled for ambulatory arthroscopic unilateral anterior cruciate ligament repair surgery with bone tendon bone autograft Exclusion Criteria: History of chronic pain syndromes Chronic opioid use (daily morphine milligram equivalents > 30 mg for at least 3 months) Contraindication to peripheral nerve blocks Contraindication to neuraxial anesthesia History of peripheral neuropathy or pre-existing neurological deficits Psychiatric or cognitive disorder that prohibit patient from following study protocol Allergy to local anesthetic or study medications Multi-ligament surgery History of substance abuse Infection at the site of injection
Sites / Locations
- HSS Sports Medicine Institute West SideRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Group 1 - Control
Group 2 - Intervention
Patients randomized to this group will receive an adductor canal block (ACB) and Infiltration between the Popliteal Artery and Capsule of the Knee (IPACK) nerve block.
Patients randomized to this group will receive an adductor canal block (ACB), Infiltration between the Popliteal Artery and Capsule of the Knee (IPACK) nerve block, and the genicular nerve block (intervention). The genicular nerve block is a total of 20cc of 0.25% bupivacaine with 2mg of preservative free dexamethasone applied to the superomedial genicular nerve, superolateral genicular nerve, inferomedial genicular nerve, and nerve to vastus intermedius.